Virtu Financial LLC Tyme Technologies, Inc. Transaction History

Virtu Financial LLC

$1.43 Billion
Q2 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 17, 2022	SELL	$0.28 - $0.68 $21,325 - $51,789	-76,161 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$0.6 - $1.04 $7,097 - $12,302	11,829 Added 18.39%	76,161 $46,000
Q3 2021 Nov 12, 2021	SELL	$0.99 - $1.38 $28,010 - $39,044	-28,293 Reduced 30.55%	64,332 $66,000
Q2 2021 Sep 17, 2021	SELL	$1.14 - $1.87 $124,316 - $203,923	-109,050 Reduced 54.07%	92,625 $117,000
Q1 2021 May 19, 2021	BUY	$1.34 - $3.53 $244,098 - $643,035	182,163 Added 933.59%	201,675 $359,000
Q4 2020 Feb 24, 2021	BUY	$0.87 - $1.26 $16,975 - $24,585	19,512 New	19,512 $24,000

About TYME TECHNOLOGIES, INC.

Ticker TYME
Exchange NASDAQ
Shares Outstandng 172,207,008
Description
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...

More about TYME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.